Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.
Akhil SanthoshVinod SharmaSameer BakhshiAkash JhaVinod SharmaPrabhat Singh MalikRaja PramanikAjay GogiaChandra Prakash PrasadTushar SehgalSneha GundArundhathi DevWinson Y CheungR M PandeySaran KumarIshaan GuptaAtul Batranull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Topical diclofenac prevented HFS in patients receiving capecitabine. This trial supports the use of topical diclofenac to prevent capecitabine-associated HFS.